Policy | 10 April 2026
NITI Aayog releases reports to improve ease of doing R&D in India
The reports will now be shared with relevant ministries and departments as a guidance framework
The reports will now be shared with relevant ministries and departments as a guidance framework
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Union Health Minister says India’s healthcare model blends traditional wisdom with modern science, backed by Ayushman Bharat and Janaushadhi expansion
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
The government has appointed Dr. Sanjay Tewari as Chairperson, National Dental Commission and Dr. Mousumi Goswami, Part-Time Member, National Dental Commission
The document, published under the Accelerating Clinical Trials in the EU (ACT EU) initiative, sets out how trials should be conducted when health emergencies disrupt normal research operations
Nadda underlined that India’s policy framework is aligned with this transformation
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
Once finalized, cough syrups will no longer be available for over-the-counter sale
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Subscribe To Our Newsletter & Stay Updated
